<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343056">
  <stage>Registered</stage>
  <submitdate>11/06/2011</submitdate>
  <approvaldate>21/06/2011</approvaldate>
  <actrnumber>ACTRN12611000627954</actrnumber>
  <trial_identification>
    <studytitle>Can regular use of the Cough Assist machine maintain lung function in children and adolescents with neuromuscular disease?</studytitle>
    <scientifictitle>Can regular use of the Cough Assist machine maintain lung function in children and adolescents with neuromuscular disease?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>neuromuscular disease with diminished lung function</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>using the Cough Assist machine every day and night (ie twice daily) taking 3-5 breaths, then coughing and repeating 3-5 cycles. For each breath there should be a 2 second inspiration and a 3 second expiration, with a 30 second rest between breaths. Pressure used fell between 30-40cm H2O but was left up to individual patient comfort,  for a period of four months. The machine is used via a face mask or mouth piece connecting the mask via a tube to the actual machine</interventions>
    <comparator>nil treatment added</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>using the Vitalograph Alpha 6000 spirometer to measure vital capacity (L), peak expiratory flow (L/min) and peak cough flow (L/min) of all participants. This will give an indication of whether lung function is being maintained.</outcome>
      <timepoint>these meaures will be taken monthly over a four month period (March 2011 - June 2011)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>nil</outcome>
      <timepoint>nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>neuromuscular disease, under 18 yrs of age, able to provide consent, English speaking,</inclusivecriteria>
    <inclusiveminage>10</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>17</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>ambulant, unable to provide appropriate spirometry measures</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment />
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>7/03/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>8</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Notre Dame Australia</primarysponsorname>
    <primarysponsoraddress>19 Mouat Street, (PO Box 1225), Fremantle, WA 6959</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Laura Gotti</fundingname>
      <fundingaddress>19 Mouat Street, (PO Box 1225), Fremantle, WA 6959</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>nil</sponsorname>
      <sponsoraddress>nil</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>the main hypothesis of this study is to prove whether using the cough assist regularly twice a day will help maintain lung function in children with neuromuscular disease</summary>
    <trialwebsite>nil</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Laura Gotti, 4th year physiotherapy student</name>
      <address>19 Mouat Street, (PO Box 1225), Fremantle, WA 6959</address>
      <phone>(61 8) 9433 0555 / FREECALL: 1800 640 500/</phone>
      <fax />
      <email>lgotti@nd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Laura Gotti, 4th year physiotherapy student</name>
      <address>19 Mouat Street, (PO Box 1225), Fremantle, WA 6959</address>
      <phone>(61 8) 9433 0555 / FREECALL: 1800 640 500/</phone>
      <fax />
      <email>lgotti@nd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>